Short answer · Medically reviewed summary · Last updated: 2026-05-08
19q13.11 Microdeletion Syndrome is a rare chromosomal disorder caused by the loss of a small segment of genetic material from the long arm of chromosome 19. This condition is characterized by a spectrum of clinical features, most notably distinctive facial features, intellectual disability, and developmental delays, though the severity of symptoms varies significantly between individuals. What causes 19q13.11 Microdeletion Syndrome? The syndrome occurs due to a submicroscopic deletion on the 19q13.11 region.
What is 19q13.11 Microdeletion Syndrome
What is 19q13.11 Microdeletion Syndrome? Plain-language, medically reviewed definition plus the lived reality told by patients.
19q13.11 Microdeletion Syndrome is a rare chromosomal disorder caused by the loss of a small segment of genetic material from the long arm of chromosome 19. This condition is characterized by a spectrum of clinical features, most notably distinctive facial features, intellectual disability, and developmental delays, though the severity of symptoms varies significantly between individuals.
What causes 19q13.11 Microdeletion Syndrome?
The syndrome occurs due to a submicroscopic deletion on the 19q13.11 region. This specific area contains several genes vital for normal development, including the MAP2K7 gene. When this genetic material is missing, the body’s instructions for growth and cognitive function are altered. Because 19q13.11 Microdeletion Syndrome is a structural chromosomal change, it is usually a "de novo" event, meaning it occurs spontaneously during the formation of reproductive cells or early embryonic development, rather than being inherited from parents.
Which body systems are affected by 19q13.11 Microdeletion Syndrome?
The clinical presentation of 19q13.11 Microdeletion Syndrome is multisystemic. While every patient's journey is unique, the following observations are frequently documented in clinical literature and reported by our 19 community members at DiseaseMaps.org:
- Neurological: Global developmental delay, speech impairment, and varying degrees of intellectual disability.
- Physical Growth: Short stature and occasional feeding difficulties in infancy.
- Craniofacial: Distinctive facial features such as a prominent forehead, down-slanting palpebral fissures, and a thin upper lip.
- Skeletal: Aplasia cutis congenita (missing patches of skin at birth) or limb abnormalities in some cases.
How rare is 19q13.11 Microdeletion Syndrome?
19q13.11 Microdeletion Syndrome is extremely rare, with only a limited number of cases reported in medical literature worldwide. Due to its rarity, it is likely underdiagnosed, and there is no established prevalence rate. Unlike more common chromosomal conditions, 19q13.11 Microdeletion Syndrome does not show a strong predilection for any specific gender or geographic population.
How is 19q13.11 Microdeletion Syndrome diagnosed?
Diagnosis is typically confirmed through chromosomal microarray analysis (CMA), a high-resolution genetic test capable of detecting small deletions that standard karyotyping might miss. Early diagnosis is essential for accessing appropriate developmental support and clinical management.
Next steps
- Consult with a clinical geneticist to review microarray results and discuss family planning.
- Connect with the 19 community members at DiseaseMaps.org to share experiences and coping strategies.
- Schedule multidisciplinary evaluations, including speech therapy, occupational therapy, and neurodevelopmental assessments.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: Portal for rare diseases and orphan drugs
- Online Mendelian Inheritance in Man (OMIM) database
- PubMed: Peer-reviewed clinical case studies on 19q13.11 deletions
